INVITAE CORPORATION

Invitae Corporation specializes in advanced genetic testing and laboratory services, delivering precision diagnostics through next-generation sequencing and molecular analysis platforms. Their core capabilities encompass clinical-grade genomic interpretation, reference laboratory operations, and the development and supply of specialized genetic testing kits for inherited conditions, oncology, and rare diseases. The contractor demonstrates deep technical expertise in high-throughput DNA sequencing, bioinformatics pipeline development, and regulatory-compliant clinical lab workflows aligned with CLIA and CAP standards. A key differentiator is their integration of diagnostic testing with research-grade data analytics, enabling scalable, evidence-based decision support for complex patient cases. The contractor maintains a sustained and primary relationship with the Department of Veterans Affairs, providing comprehensive genetic laboratory services including reference testing, diagnostic kit provisioning, and research-supported laboratory operations. Their work for the VA consistently centers on expanding access to genomic medicine for veteran populations, supporting personalized care pathways through scalable, high-volume testing infrastructure. Invitae’s primary industry focus is in medical laboratories (NAICS 621511), where they operate as a high-complexity clinical diagnostics provider. They also engage in research and development of life science technologies and the manufacturing of specialized medical instruments, positioning them at the intersection of diagnostic service delivery and innovation in genomic tooling. Their market presence is defined by end-to-end solutions—from sample processing to clinical reporting—that bridge laboratory science and patient care. As a privately held entity headquartered in San Francisco, Invitae Corporation operates with a strong emphasis on scalable, technology-driven diagnostics. While no formal government certifications are listed, their laboratory operations adhere to federal clinical quality standards, and their geographic footprint supports national service delivery to federal health systems through centralized, accredited testing facilities.